Skip to main content
Biochemical Journal logoLink to Biochemical Journal
. 2003 Jan 1;369(Pt 1):31–37. doi: 10.1042/BJ20020419

Restoration of high-level transport activity by human reduced folate carrier/ThTr1 thiamine transporter chimaeras: role of the transmembrane domain 6/7 linker region in reduced folate carrier function.

Xiang Y Liu 1, Teah L Witt 1, Larry H Matherly 1
PMCID: PMC1223057  PMID: 12227830

Abstract

The reduced folate carrier (RFC; SLC19A1) is closely related to the thiamine transporter, SLC19A2 (ThTr1). Hydropathy models for these homologous transporters predict up to 12 transmembrane domains (TMDs), with internally oriented N- and C-termini and a large central loop between TMDs 6 and 7. The homologies are localized mostly in the TMDs. However, there is little similarity in their N- and C-terminal domains and the central peptide linkers connecting putative TMDs 1-6 and TMDs 7-12. To explore the functional role of the 61-amino acid central linker in the human RFC (hRFC), we introduced deletions of 49 and 60 amino acids into this region, differing by the presence of a stretch of 11 highly conserved amino acids between the human and rodent RFCs (positions 204-214). An additional hRFC construct was prepared in which only the 11 conserved amino acids were deleted. The resulting hRFC(D215-R263 Delta), hRFC(K204-R263 Delta) and hRFC(K204-R214 Delta) proteins were transfected into transport-impaired K562 cells. The deletion constructs were all expressed in plasma membranes; however, they were completely inactive for methotrexate and (6 S )5-formyl tetrahydrofolate transport. Insertion of non-homologous 73- and 84-amino acid fragments from the structurally analogous ThTr1 linker region into position 204 of hRFC(K204-R263 Delta) restored low levels of transport (16-21% of the wild type). Insertion of the ThTr1 linkers into hRFC(D215-R263 Delta) at position 215 restored 60-80% of wild-type levels of transport. Collectively, our results suggest that the role of the hRFC linker peptide is to provide the proper spatial orientation between the two halves of the hRFC protein for optimal function, and that this is largely independent of amino acid sequence. Our results also demonstrate a critical transport role for the stretch of 11 conserved amino acids starting at position 204 of hRFC.

Full Text

The Full Text of this article is available as a PDF (202.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Diaz G. A., Banikazemi M., Oishi K., Desnick R. J., Gelb B. D. Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome. Nat Genet. 1999 Jul;22(3):309–312. doi: 10.1038/10385. [DOI] [PubMed] [Google Scholar]
  2. Dixon K. H., Lanpher B. C., Chiu J., Kelley K., Cowan K. H. A novel cDNA restores reduced folate carrier activity and methotrexate sensitivity to transport deficient cells. J Biol Chem. 1994 Jan 7;269(1):17–20. [PubMed] [Google Scholar]
  3. Dutta B., Huang W., Molero M., Kekuda R., Leibach F. H., Devoe L. D., Ganapathy V., Prasad P. D. Cloning of the human thiamine transporter, a member of the folate transporter family. J Biol Chem. 1999 Nov 5;274(45):31925–31929. doi: 10.1074/jbc.274.45.31925. [DOI] [PubMed] [Google Scholar]
  4. Eudy J. D., Spiegelstein O., Barber R. C., Wlodarczyk B. J., Talbot J., Finnell R. H. Identification and characterization of the human and mouse SLC19A3 gene: a novel member of the reduced folate family of micronutrient transporter genes. Mol Genet Metab. 2000 Dec;71(4):581–590. doi: 10.1006/mgme.2000.3112. [DOI] [PubMed] [Google Scholar]
  5. Ferguson P. L., Flintoff W. F. Topological and functional analysis of the human reduced folate carrier by hemagglutinin epitope insertion. J Biol Chem. 1999 Jun 4;274(23):16269–16278. doi: 10.1074/jbc.274.23.16269. [DOI] [PubMed] [Google Scholar]
  6. Fleming J. C., Steinkamp M. P., Kawatsuji R., Tartaglini E., Pinkus J. L., Pinkus G. S., Fleming M. D., Neufeld E. J. Characterization of a murine high-affinity thiamine transporter, Slc19a2. Mol Genet Metab. 2001 Sep-Oct;74(1-2):273–280. doi: 10.1006/mgme.2001.3241. [DOI] [PubMed] [Google Scholar]
  7. Fry D. W., Yalowich J. C., Goldman I. D. Rapid formation of poly-gamma-glutamyl derivatives of methotrexate and their association with dihydrofolate reductase as assessed by high pressure liquid chromatography in the Ehrlich ascites tumor cell in vitro. J Biol Chem. 1982 Feb 25;257(4):1890–1896. [PubMed] [Google Scholar]
  8. Horton R. M., Cai Z. L., Ho S. N., Pease L. R. Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. Biotechniques. 1990 May;8(5):528–535. [PubMed] [Google Scholar]
  9. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  10. Labay V., Raz T., Baron D., Mandel H., Williams H., Barrett T., Szargel R., McDonald L., Shalata A., Nosaka K. Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness. Nat Genet. 1999 Jul;22(3):300–304. doi: 10.1038/10372. [DOI] [PubMed] [Google Scholar]
  11. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  12. Liu X. Y., Matherly L. H. Functional interactions between arginine-133 and aspartate-88 in the human reduced folate carrier: evidence for a charge-pair association. Biochem J. 2001 Sep 1;358(Pt 2):511–516. doi: 10.1042/0264-6021:3580511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Liu Xiang Y., Matherly Larry H. Analysis of membrane topology of the human reduced folate carrier protein by hemagglutinin epitope insertion and scanning glycosylation insertion mutagenesis. Biochim Biophys Acta. 2002 Aug 31;1564(2):333–342. doi: 10.1016/s0005-2736(02)00467-4. [DOI] [PubMed] [Google Scholar]
  14. Matherly L. H., Czajkowski C. A., Angeles S. M. Identification of a highly glycosylated methotrexate membrane carrier in K562 human erythroleukemia cells up-regulated for tetrahydrofolate cofactor and methotrexate transport. Cancer Res. 1991 Jul 1;51(13):3420–3426. [PubMed] [Google Scholar]
  15. Matherly L. H. Molecular and cellular biology of the human reduced folate carrier. Prog Nucleic Acid Res Mol Biol. 2001;67:131–162. doi: 10.1016/s0079-6603(01)67027-2. [DOI] [PubMed] [Google Scholar]
  16. Matsudaira P. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J Biol Chem. 1987 Jul 25;262(21):10035–10038. [PubMed] [Google Scholar]
  17. Moscow J. A., Gong M., He R., Sgagias M. K., Dixon K. H., Anzick S. L., Meltzer P. S., Cowan K. H. Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells. Cancer Res. 1995 Sep 1;55(17):3790–3794. [PubMed] [Google Scholar]
  18. Oishi K., Hirai T., Gelb B. D., Diaz G. A. Slc19a2: cloning and characterization of the murine thiamin transporter cDNA and genomic sequence, the orthologue of the human TRMA gene. Mol Genet Metab. 2001 Jun;73(2):149–159. doi: 10.1006/mgme.2001.3184. [DOI] [PubMed] [Google Scholar]
  19. Prasad P. D., Ramamoorthy S., Leibach F. H., Ganapathy V. Molecular cloning of the human placental folate transporter. Biochem Biophys Res Commun. 1995 Jan 17;206(2):681–687. doi: 10.1006/bbrc.1995.1096. [DOI] [PubMed] [Google Scholar]
  20. Rajgopal A., Edmondnson A., Goldman I. D., Zhao R. SLC19A3 encodes a second thiamine transporter ThTr2. Biochim Biophys Acta. 2001 Nov 29;1537(3):175–178. doi: 10.1016/s0925-4439(01)00073-4. [DOI] [PubMed] [Google Scholar]
  21. Sadlish Heather, Williams Frederick M. R., Flintoff Wayne F. Cytoplasmic domains of the reduced folate carrier are essential for trafficking, but not function. Biochem J. 2002 Jun 15;364(Pt 3):777–786. doi: 10.1042/BJ20011361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sharina Iraida G., Zhao Rongbao, Wang Yanhua, Babani Solomon, Goldman I. David. Role of the C-terminus and the long cytoplasmic loop in reduced folate carrier expression and function. Biochem Pharmacol. 2002 May 1;63(9):1717–1724. doi: 10.1016/s0006-2952(02)00955-3. [DOI] [PubMed] [Google Scholar]
  23. Sirotnak F. M., Tolner B. Carrier-mediated membrane transport of folates in mammalian cells. Annu Rev Nutr. 1999;19:91–122. doi: 10.1146/annurev.nutr.19.1.91. [DOI] [PubMed] [Google Scholar]
  24. Williams F. M., Flintoff W. F. Isolation of a human cDNA that complements a mutant hamster cell defective in methotrexate uptake. J Biol Chem. 1995 Feb 17;270(7):2987–2992. doi: 10.1074/jbc.270.7.2987. [DOI] [PubMed] [Google Scholar]
  25. Williams F. M., Murray R. C., Underhill T. M., Flintoff W. F. Isolation of a hamster cDNA clone coding for a function involved in methotrexate uptake. J Biol Chem. 1994 Feb 25;269(8):5810–5816. [PubMed] [Google Scholar]
  26. Wong S. C., McQuade R., Proefke S. A., Bhushan A., Matherly L. H. Human K562 transfectants expressing high levels of reduced folate carrier but exhibiting low transport activity. Biochem Pharmacol. 1997 Jan 24;53(2):199–206. doi: 10.1016/s0006-2952(96)00710-1. [DOI] [PubMed] [Google Scholar]
  27. Wong S. C., Proefke S. A., Bhushan A., Matherly L. H. Isolation of human cDNAs that restore methotrexate sensitivity and reduced folate carrier activity in methotrexate transport-defective Chinese hamster ovary cells. J Biol Chem. 1995 Jul 21;270(29):17468–17475. doi: 10.1074/jbc.270.29.17468. [DOI] [PubMed] [Google Scholar]
  28. Wong S. C., Zhang L., Proefke S. A., Matherly L. H. Effects of the loss of capacity for N-glycosylation on the transport activity and cellular localization of the human reduced folate carrier. Biochim Biophys Acta. 1998 Oct 15;1375(1-2):6–12. doi: 10.1016/s0005-2736(98)00118-7. [DOI] [PubMed] [Google Scholar]
  29. Wong S. C., Zhang L., Witt T. L., Proefke S. A., Bhushan A., Matherly L. H. Impaired membrane transport in methotrexate-resistant CCRF-CEM cells involves early translation termination and increased turnover of a mutant reduced folate carrier. J Biol Chem. 1999 Apr 9;274(15):10388–10394. doi: 10.1074/jbc.274.15.10388. [DOI] [PubMed] [Google Scholar]
  30. Zhao R., Gao F., Wang Y., Diaz G. A., Gelb B. D., Goldman I. D. Impact of the reduced folate carrier on the accumulation of active thiamin metabolites in murine leukemia cells. J Biol Chem. 2001 Jan 12;276(2):1114–1118. doi: 10.1074/jbc.M007919200. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES